Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPH3127 in mild to moderate primary hypertension (phase II, China)
CTR20181559Phase 2Completed
- Sponsor
- Shanghai Pharmaceuticals Holding Co Ltd
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sitokiren in essential hypertension, sponsored by Shanghai Pharmaceuticals Holding Co Ltd. Started Sep 2018; status: completed.
02
Drugs
sitokiren
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20181559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181559.